GSK Dodges Putative Class Claims Over Avandia Payments
A Pennsylvania federal judge on Wednesday tossed out four putative class actions against GlaxoSmithKline PLC, in which the plaintiffs sought refunds of the co-pays and other money they spent on purchasing...To view the full article, register now.
Already a subscriber? Click here to view full article